Shiraj Sen: Presenting Emerging ADC Clinical Trial Data in Small Cell Lung Cancer at Best of ASCO Dallas
Shiraj Sen, Medical Oncologist, Director of NEXT Oncology–Dallas, and Principal Investigator of Multiple Early-Phase Clinical Trials, Shared on LinkedIn: “Thanks to Total Health and Program Chair…
Read the full articleYou might also wanna read
A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
Conditions : Chronic Myeloid Leukemia Sponsors : Novartis Pharmaceuticals Not yet recruiting
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
Scientists have expressed ‘excitement’ over the potential new treatment for advanced adrenocortical carcinoma (ACC)
A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials
Conditions : Participants Treated With Senza5 Interventions : Biological: Senza5 CART5 Sponsors : Vittoria Biotherapeutics Not yet recruitin
From Bench to Bedside: Non-Small Cell Lung Cancer Discovery Creates Hope
Afshin Dowlait, MD describes how his team of researchers discovered a new non-small cell lung cancer subtype in the laboratory and brought a
<![CDATA[Sequencing ADCs and Managing Ocular Toxicities in Breast Cancer Populations]]>
First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors
Conditions : Advanced Solid Tumor; Metastatic Solid Tumor; Unresectable Solid Tumor Interventions : Drug: DS1025a Sponsors : Daiichi Sankyo
Comments
Sign in to join the conversation.
No comments yet. Be the first.